Pharmosa Biopharm Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2018 - 2019
Period Ending	Aug '25 Aug 14, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2018 - 2019
Market Capitalization	5,777	6,829	10,314	7,055	-	-	Upgrade
Market Cap Growth	-40.90%	-33.79%	46.18%	-	-	-	Upgrade
Enterprise Value	4,590	5,338	9,330	6,778	-	-	Upgrade
Last Close Price	44.75	52.90	88.00	62.22	-	-	Upgrade
PE Ratio	-	-	1219.72	-	-	-	Upgrade
PS Ratio	33.27	40.75	32.80	-	-	-	Upgrade
PB Ratio	3.37	3.52	9.07	9.27	-	-	Upgrade
P/TBV Ratio	3.38	3.53	9.07	9.27	-	-	Upgrade
P/OCF Ratio	-	-	327.98	-	-	-	Upgrade
EV/Sales Ratio	26.44	31.86	29.67	-	-	-	Upgrade
EV/EBITDA Ratio	-	-	3121.44	-	-	-	Upgrade
Debt / Equity Ratio	0.06	0.06	0.13	0.03	0.07	0.31	Upgrade
Debt / EBITDA Ratio	-	-	7.04	-	-	-	Upgrade
Asset Turnover	0.08	0.10	0.30	-	-	-	Upgrade
Inventory Turnover	1.36	1.74	-	-	-	-	Upgrade
Quick Ratio	13.49	14.03	12.58	24.23	13.96	4.18	Upgrade
Current Ratio	14.27	14.48	13.02	24.65	14.39	4.31	Upgrade
Return on Equity (ROE)	-15.22%	-10.84%	0.89%	-41.24%	-54.73%	-103.22%	Upgrade
Return on Assets (ROA)	-8.46%	-7.81%	-0.17%	-24.49%	-28.67%	-35.08%	Upgrade
Return on Capital (ROIC)	-8.86%	-8.19%	-0.17%	-25.13%	-29.48%	-36.52%	Upgrade
Earnings Yield	-4.88%	-2.44%	0.08%	-3.78%	-	-	Upgrade
FCF Yield	-7.50%	-4.28%	-0.48%	-3.81%	-	-	Upgrade
Buyback Yield / Dilution	-7.59%	-11.49%	-15.09%	-16.02%	-78.34%	-27.94%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.